Camber Pharma Launches Generic Bystolic®

Piscataway, NJ, September 17, 2021– Camber Pharmaceuticals is pleased to announce that it has launched Nebivolol Tablets to their current portfolio, which is the generic version of Bystolic®
Nebivolol Tablets are used to treat hypertension (high blood pressure).
Nebivolol Tablets from Camber are available in 2.5mg-30ct as well as 5mg, 10mg and 20mg in 30 and 90 count bottles.
Recent articles
- Camber Launches Temozolomide Capsules, USP
- Camber Launches Eltrombopag Tablets & Oral Suspension
- Camber Launches Eslicarbazepine Acetate Tablets
- Camber Launches Phenylephrine Hydrochloride Injection, USP
- Camber Launches Chlorzoxazone Tablets, USP
- Camber Launches 13 New Generic Products in Q1 2025, Sets Ambitious Pace for the Year